Hodgetts, S I <br/><br/>
Complement and myoblast transfer therapy: donor myoblast survival is enhanced following depletion of host complement C3 using cobra venom factor, but not in the absence of C5.  [electronic resource] 

 -  Immunology and cell biology  Jun 2001 
 - 231-9 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0818-9641 
<br/><br/><label>Standard No.: </label>10.1046/j.1440-1711.2001.01006.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Cell Survival--drug effects<br/>Cell Transplantation--methods<br/>Cells, Cultured<br/>Complement C3--immunology<br/>Complement C5--immunology<br/>Complement Inactivator Proteins--pharmacology<br/>Elapid Venoms--pharmacology<br/>Female<br/>Humans<br/>Immunohistochemistry<br/>Male<br/>Mice<br/>Mice, Inbred C57BL<br/>Mice, Inbred DBA<br/>Muscle, Skeletal--cytology<br/>Muscular Dystrophy, Duchenne--therapy